Drugmaker Mallinckrodt is considering options including a repeat bankruptcy filing after emerging from chapter 11 last year as a $200 million opioid settlement payment comes due within weeks, people familiar with the matter said.
The Dublin-based drugmaker is required to make the payment to an opioid-victims compensation trust by mid-June under a $1.7 billion settlement as part of its chapter 11 exit plan. A lender group advised by law firm Gibson Dunn & Crutcher has been in discussions with the company about how it can deal…